China has the world's largest population and is quickly emerging to become the second biggest healthcare market. It is also the world's biggest producer and exporter of pharmaceutical ingredients.
Over the past decade, China has become the focal point for international companies due to high-skill and low cost labour power. In addition, the market has seen growth in numerous development, innovation and collaboration opportunities with domestic pharmaceutical companies.
To drive support and shape the future of Chinese pharmaceutical companies, CPhI China brings together domestic and international companies, covering every step of the pharma supply chain to do business, share ideas, learn and drive innovation in China.